Group Calls for Ban of Abbott's ADD Drug (Reuters)


Reuters - A 30-year-old Abbott Laboratories
Inc. drug for attention deficit disorder poses an unacceptable
risk of deadly liver damage and should be banned immediately, a
U.S. consumer group said on Thursday.

Read more...